Lamivudine therapy for chronic hepatitis b virus infection and pregnancy: A case report

International Journal of Infectious Diseases

Volumn 5, Issue 2, 2001, Pages 115-116

  Tomasiewicz, Krzysztof ^a   Modrzewska, Roma ^a   Krawczuk, Grazyna ^a   Lyczak, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; PREGNANCY; PREVALENCE; REVERSE TRANSCRIPTION; TREATMENT INDICATION; VIRUS INFECTION;

EID: 0034937279     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(01)90038-4     Document Type: Article

References (12)

1. Clinical pharmacokinetics of lamivudine
2. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate
3. Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy
4. Lamivudine as initial treatment for chronic hepatitis B in the United States
5. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial
6. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
7. A one-year trial of lamivudine for chronic hepatitis B
8. Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy
9. Antiretroviral therapy for pregnant women
10. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring
11. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
12. Combined stavudine and lamivudine during pregnancy